:quality(90))
With over 20 years of experience, our Phase I flagship site in Warsaw, Poland, has successfully conducted 280+ clinical research projects and completed 65 audits, including 2 FDA inspections with NAI results.
We provide full-service solutions and specialize in:
:quality(90))
Early Phases (FIH, SAD, MAD)
Bioequivalence & biosimilarity
Proof-of-Concept & PK/PD studies
Special populations
Tobacco risk evaluation & smoking cessation
Clinical & non-clinical trial strategy and consulting
Medical writing: Protocols, ICF, CRF, Final Clinical Reports
Regulatory approval support
Project management and study monitoring
Clinical study conduct (including subject reimbursement)
Pharmacokinetics & biostatistics
Bioequivalence & biosimilarity (healthy volunteers & patients)
Proof-of-Concept and food effect studies
Studies involving special populations
First-in-human studies
PK/PD, SAD, MAD
Phase I/II/III across various indications
Tobacco risk & smoking cessation studies
Discover how our flexible approach can support your unique study needs.
